Engineering Viruses to Target & Destroy Cancer
Precision-designed therapies that seek out and eliminate cancer cells.
Latest News
New posts, press, and platform updates.
Core tech - Jan 2026
Update on selective replication mechanism
Update on how we use aptazyme to control replication to make our viral cancer therapies much more selective.
Read → Announcement - Nov 2025Manufacturing partnership with Genezen
We’ve partnered with Genezen to start cGMP manufacturing of our lead oncolytic virus candidate.
Read → Announcement - July 2025New Home at Alexandria LaunchLabs
We have moved from our founding location at BioLabs@NYU Langone to Alexandria LaunchLabs, a leading life sciences innovation space in New York City.
Read →